Lyme disease secondary prevention: Difference between revisions
Jump to navigation
Jump to search
m Changes made per Mahshid's request |
Category |
||
Line 34: | Line 34: | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Ophthalmology]] | |||
[[Category:Neurology]] | |||
[[Category:Dermatology]] | |||
[[Category:Cardiology]] | |||
[[Category:Rheumatology]] |
Revision as of 18:11, 21 September 2017
Lyme disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Lyme disease secondary prevention On the Web |
American Roentgen Ray Society Images of Lyme disease secondary prevention |
Risk calculators and risk factors for Lyme disease secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
The secondary prevention of Lyme disease may include post exposure prophylaxis with doxycycline in select cases meeting criteria for chemoprophylaxis.
Secondary prevention
- After a tick bite, routine use of antibiotic prophylaxis is not recommended.
- The secondary prevention of Lyme disease may include post exposure prophylaxis with doxycycline in selected cases meeting criteria for chemoprophylaxis.
- The criteria for chemoprophylaxis includes:[1]
- A single dose of doxycycline (avoid in pregnancy and children <8 years) may be offered to adults (200mg) and children (4mg/kg, maximum 200mg) if all of the following criteria are fulfilled:
- The tick is identified as I. scapularis (adult or nymph).
- The tick has been attached for > 36 hours. Attachment time is estimated by the degree of engorgement of the tick with blood or approximating the time of exposure to the tick.
- Prophylaxis should be stated within 72 hours of tick removal.
- Local infection rate of ticks with B. burgdorferi is > 20%.
- There is no contraindication to use of doxycycline.
References
- ↑ Wormser GP, Dattwyler RJ, Shapiro ED, Halperin JJ, Steere AC, Klempner MS; et al. (2006). "The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America". Clin Infect Dis. 43 (9): 1089–134. doi:10.1086/508667. PMID 17029130.
Categories:
- CS1 maint: Explicit use of et al.
- CS1 maint: Multiple names: authors list
- Needs overview
- Bacterial diseases
- Insect-borne diseases
- Lyme disease
- Zoonoses
- Spirochaetes
- Disease
- Dermatology
- Emergency medicine
- Intensive care medicine
- Emergency mdicine
- Primary care
- Up-To-Date
- Infectious disease
- Ophthalmology
- Neurology
- Cardiology
- Rheumatology